Cytomegalovirus Infection
📧 Sign up to get email alerts when something new happens for Cytomegalovirus Infection.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-04-15Clinical Trial Update: Donor Virus-Specific CMV or AdV CTL to Treat CMV or AdV Reactivation or Disease After Solid Organ or HCT [EARLY_Phase 1]
Early-phase 1 clinical trial evaluating donor-virus-specific CMV- and AdV-directed cytotoxic T lymphocytes to prevent or treat CMV or adenov…
-
CLINICAL_TRIALS trial_result · 2026-04-13Clinical Trial Update: A Study of Cytomegalovirus Disease Epidemiology in Pediatric and Adult Liver Transplant Recipients in China
This clinical trial update summarizes the epidemiology of Cytomegalovirus infection in both pediatric and adult liver transplant recipients …
-
CLINICAL_TRIALS trial_result · 2026-04-09Clinical Trial Update: Letermovir for CMV Prevention After Lung Transplantation [Phase 2]
Phase 2 trial evaluating letermovir for CMV prevention after lung transplantation has completed and posted results.
-
CLINICAL_TRIALS trial_result · 2026-04-03Clinical Trial Update: Prenatal Behavioral Intervention to Prevent Maternal Cytomegalovirus (CMV) in Pregnancy [NA]
A completed clinical trial evaluated a prenatal behavioral intervention aimed at preventing maternal cytomegalovirus infection and congenita…
-
CLINICAL_TRIALS trial_result · 2026-03-27Clinical Trial Update: CMV T Cell Immunity in Pediatric Solid Organ Transplant Recipients
This entry notes the completed status of a pediatric solid organ transplant CMV immunity trial (NCT03924219) with listed infection-related c…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-03-16Clinical Trial Update: A Study to Evaluate the Efficacy, Safety, and Immunogenicity of mRNA-1647 Cytomegalovirus (CMV) Vaccine in Allogenic Hematopoietic Cell Transplantation (HCT) Participants. [Phase 2]
Phase 2 clinical trial evaluating the efficacy, safety, and immunogenicity of the mRNA-1647 cytomegalovirus vaccine in participants undergoi…
-
CLINICAL_TRIALS trial_result · 2026-03-12Clinical Trial Update: A Study of Modified mRNA Vaccines in Healthy Adults [Phase 1]
A Phase 1 study of modified mRNA vaccines in healthy adults sponsored by ModernaTX, Inc. has completed, evaluating vaccines targeting COVID-…
-
CLINICAL_TRIALS trial_result · 2026-03-02Clinical Trial Update: A Study of Safety and Immune Response to Different Doses of a Cytomegalovirus Vaccine in Healthy Adults [Phase 1, Phase 2]
GlaxoSmithKline conducted a Phase 1/2 trial to assess safety and immune response to multiple doses of a cytomegalovirus vaccine in healthy a…
-
CLINICAL_TRIALS trial_result · 2026-02-18Clinical Trial Update: Tissue Cytomegalovirus Viral Load and Associated Factors in Pediatric Patients Undergoing Colonoscopy
A completed clinical trial evaluated tissue cytomegalovirus viral load and associated factors in pediatric patients undergoing colonoscopy, …
-
CLINICAL_TRIALS trial_result · 2026-02-05Clinical Trial Update: Clinical and Genetic Analysis of Enlarged Vestibular Aqueducts
This clinical trial update reports on the clinical and genetic analysis of enlarged vestibular aqueducts in patients with sensorineural hear…
-
CLINICAL_TRIALS trial_result · 2026-02-02Clinical Trial Update: A Long-Term Extension Study to Evaluate the Immunogenicity and Safety of Cytomegalovirus (CMV) mRNA-1647 Vaccine [Phase 2]
Long-term extension study (Phase 2) evaluating immunogenicity and safety of CMV vaccine mRNA-1647; the trial has completed.
-
CLINICAL_TRIALS trial_result · 2026-01-30Clinical Trial Update: ValgaNciclovIR for CMV Viraemia in AdvaNced HIV diseAse [Phase 2]
A Phase 2 clinical trial evaluating valganciclovir for cytomegalovirus viraemia in advanced HIV disease is not yet recruiting.
-
CLINICAL_TRIALS trial_result · 2026-01-29Clinical Trial Update: A Study of Cytomegalovirus (CMV) Infection After Kidney Transplant in Adults in the United Kingdom
This clinical trial update reports a completed study on Cytomegalovirus infection in adult kidney transplant recipients in the United Kingdo…
-
CLINICAL_TRIALS trial_result · 2025-12-15Clinical Trial Update: A Study to Evaluate the Efficacy, Safety, and Immunogenicity of mRNA-1647 Cytomegalovirus (CMV) Vaccine in Healthy Participants 16 to 40 Years of Age [Phase 3]
A Phase 3 trial evaluating the mRNA-1647 cytomegalovirus vaccine in healthy adults was terminated; this update reports the study status.
-
CLINICAL_TRIALS trial_result · 2025-12-04Clinical Trial Update: Feasibility of Saliva and Remote Monitoring of Active Cytomegalovirus (CMV) Infection and Symptoms During Ovarian Cancer Treatment
This completed feasibility trial evaluated saliva-based and remote monitoring approaches for detecting active cytomegalovirus infection and …
-
CLINICAL_TRIALS trial_result · 2025-12-04Clinical Trial Update: Cytomegalovirus (CMV) Vaccines: Reinfection and Antigenic Variation [NA]
This completed clinical trial update discusses cytomegalovirus vaccines and challenges related to reinfection and antigenic variation. The s…
-
CLINICAL_TRIALS trial_result · 2025-10-07Clinical Trial Update: Maribavir vs. Valganciclovir for CMV Prophylaxis in High-Risk Kidney Transplant Recipients [Phase 4]
Phase 4 trial comparing maribavir vs valganciclovir for CMV prophylaxis in high-risk kidney transplant recipients has completed.
-
CLINICAL_TRIALS trial_result · 2025-09-30Clinical Trial Update: Efficacy and Safety of Cytotect®CP, Hyperimmune Anti-CMV IVIg as CMV Prophylaxis in Patients Developing Acute Grade II-IV GVHD After Allogeneic Hematopoietic Cell Transplantation. [Phase 2]
Phase 2 study evaluating Cytotect CP, a hyperimmune anti-CMV IVIg, as prophylaxis against cytomegalovirus infection in patients with acute g…
-
CLINICAL_TRIALS trial_result · 2025-09-22Clinical Trial Update: A Study of Human Cytomegalovirus (HCMV) Vaccine SPYVLP01 With and Without Adjuvants [Phase 1]
A Phase 1 clinical trial update evaluating the SPYVLP01 human cytomegalovirus vaccine, with and without adjuvants, has completed.
-
CLINICAL_TRIALS trial_result · 2025-09-19Clinical Trial Update: Empirical Treatment Against Cytomegalovirus and Tuberculosis in HIV-infected Infants With Severe Pneumonia [Phase 2, Phase 3]
A clinical trial update reports a Phase 2/Phase 3 study evaluating empirical treatment for cytomegalovirus and tuberculosis in HIV-infected …
-
CLINICAL_TRIALS trial_result · 2025-09-18Clinical Trial Update: Clinical Performance of SE-SPTM-PCR in Detecting Hcmv-miR-UL22A-5p After Hematopoietic Stem Cell Transplantation
The trial evaluated the clinical performance of SE-SPTM-PCR for detecting HCMV-miR-UL22A-5p after hematopoietic stem cell transplantation; t…
-
CLINICAL_TRIALS trial_result · 2025-09-05Clinical Trial Update: Injection of CD4 and CD8 + T Cells Anti-Cytomegalovirus (CMV) or Anti-adenovirus [Phase 1, Phase 2]
This clinical trial update reports the completion of Phase 1/2 trials evaluating injections of CD4+ and CD8+ T cells targeting cytomegalovir…
-
CLINICAL_TRIALS trial_result · 2025-08-08Clinical Trial Update: A Study of Maribavir in Adults With Post-transplant Cytomegalovirus (CMV) Infection
A completed clinical trial evaluating maribavir for post-transplant Cytomegalovirus infection in adults.
-
CLINICAL_TRIALS trial_result · 2025-08-01Clinical Trial Update: Assessing the Risk of CMV Infection of the Renal Transplant About R + by Cellular Immunity Analyzed by the QuantiFERON ®-CMV Test.
This clinical trial update notes that the study assessing CMV infection risk in renal transplant recipients using the QuantiFERON-CMV test h…
-
CLINICAL_TRIALS trial_result · 2025-07-30Clinical Trial Update: A Study of the Drug Letermovir (LTV) as Prevention for Recurrent of Cytomegalovirus (CMV) Infection [Phase 2]
Phase 2 trial evaluating letermovir (Prevymis) for preventing recurrent cytomegalovirus infection in hematopoietic cell transplant recipient…